RYLAN WELLS: Open Payments
NPI 1528788809 · MOBILE, AL. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$916 in 44 payments from 15 companies in 2025. Trend: 2023 $1,430 · 2024 $830 · 2025 $916
Food & beverage: $916
| Company | Payments | Amount |
|---|---|---|
| Janssen Biotech, Inc. | 8 | $199 |
| Sumitomo Pharma America, Inc. | 8 | $139 |
| Merck Sharp & Dohme LLC | 4 | $94 |
| UROGEN PHARMA, INC. | 4 | $84 |
| Endo USA, Inc. | 3 | $77 |
| Bayer Healthcare Pharmaceuticals Inc. | 4 | $75 |
| Novartis Pharmaceuticals Corporation | 4 | $61 |
| Antares Pharma, Inc. | 2 | $31 |
| Tempus AI, Inc | 1 | $25 |
| ACCORD HEALTHCARE, INC. | 1 | $25 |
Products named: ERLEADA, GEMTESA, AVEED, Nubeqa, LYNPARZA, PLUVICTO, ORGOVYX, XYOSTED.
Industry payments across AL — which companies pay providers there.
